Drugs / Pro-Bone
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01397838 | Sep → Dec 2011 | osteoporosis | OsteoBuild Ltd. | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Pro-bone | “Recent studies have shown that inhibition of Aquaporine-9 channels may ameliorate the bone degradation process. Pro-bone is an AQ - 9 channels inhibitor.” NCT01397838 ↗ |
| Action | Inhibit | “Pro-bone is an AQ - 9 channels inhibitor.” NCT01397838 ↗ |
| Route | Oral | “Oral Pro-boneTM” NCT01397838 ↗ |